share_log

康寧傑瑞製藥-B:自願公告 - KN026獲國家藥監局突破性治療藥物認定

ALPHAMAB-B: VOLUNTARY ANNOUNCEMENT - KN026 WAS GRANTED BREAKTHROUGH THERAPY DESIGNATION BY THE NMPA

香港交易所 ·  Nov 6, 2023 03:55
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more